U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H6N2
Molecular Weight 94.1147
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-AMINOPYRIDINE

SMILES

c1ccnc(c1)N

InChI

InChIKey=ICSNLGPSRYBMBD-UHFFFAOYSA-N
InChI=1S/C5H6N2/c6-5-3-1-2-4-7-5/h1-4H,(H2,6,7)

HIDE SMILES / InChI

Molecular Formula C5H6N2
Molecular Weight 94.1147
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
A synthetic analogue of the active site of Fe-containing nitrile hydratase with carboxamido N and thiolato S as donors: synthesis, structure, and reactivities.
2001 Apr 11
Synthesis and biological activity of analogues of the antidiabetic/antiobesity agent 3-guanidinopropionic acid: discovery of a novel aminoguanidinoacetic acid antidiabetic agent.
2001 Apr 12
An experimental and theoretical investigation of the carbon dioxide insertion process into the tungsten-nitrogen bond of an anionic W(0) complex.
2001 Apr 23
Structural characterization of fucose-containing oligosaccharides by high-performance liquid chromatography and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
2001 Feb
Dinuclear and heteropolynuclear complexes containing Mo2(4+) units.
2001 Jan 29
Synthesis, molecular modeling and QSAR studies in chiral 2,3-disubstituted-1,2,3,4-tetrahydro-9H-pyrido(3,4-b)indoles as potential modulators of opioid antinociception.
2001 Jun
N-glycan structures from the major glycoproteins of pigeon egg white: predominance of terminal Galalpha(1)Gal.
2001 Jun 29
Glycoproteins secreted from suspension-cultured tobacco BY2 cells have distinct glycan structures from intracellular glycoproteins.
2001 Nov
Spectral characteristics of 2-(4'-N,N-dimethylaminophenyl)pyrido[3,4-d]imidazole in AOT/n-heptane/water reverse micelles.
2001 Nov
Structural analysis of the sugar chains of human urinary thrombomodulin.
2001 Oct
N-linked oligosaccharides of glycoproteins from Ginkgo biloba pollen, an allergenic pollen.
2001 Sep
Synthesis and cytotoxic activity of benzophenanthrolinone analogues of acronycine.
2001 Sep
Synthesis of some new quinoline derivatives: new routes to synthesize polysubstituted 2(1H)-quinolone derivatives.
2001 Sep-Oct
Properties of some alkyl substituted phthalocyanines and related macrocycles.
2002
The nature of the receptor site for the reversible K+ channel blocking by aminopyridines.
2002 Apr 10
Studies on synthesis and infrared and fluorescence spectra of new europium and terbium complexes with an amide-based open-chain crown ether.
2002 Aug
Analysis of fluorogenic Smith degradation products of 7-(1,3-disulfonaphtyl)amino-disaccharides for linkage position analysis of carbohydrates.
2002 Dec
An NMR investigation of the conformational equilibria of 2-(2'-pyridyl)ethylphosphonic acid in several solvents.
2002 Feb-Mar
Characterization of glycosphingolipids from Schistosoma mansoni eggs carrying Fuc(alpha1-3)GalNAc-, GalNAc(beta1-4)[Fuc(alpha1-3)]GlcNAc- and Gal(beta1-4)[Fuc(alpha1-3)]GlcNAc- (Lewis X) terminal structures.
2002 Jan
Analysis of alpha-amylase-derived pyridylamino-dextran sulfate oligomers by the combination of size-exclusion and reversed-phase high-performance liquid chromatography.
2002 Jan 25
A convenient synthesis of 2-(alkylamino)pyridines.
2002 Jul 12
Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI).
2002 Jul 18
Synthesis and biological evaluation of aroylguanidines related to amiloride as inhibitors of the human platelet Na(+)/H(+) exchanger.
2002 Jun
Potentiometric and spectrofluorimetric studies on complexation of tenoxicam with some metal ions.
2002 Jun 1
New stereoselective reaction of methylglyoxal with 2-aminopyridine and adenine derivatives: formation of imino acid-nucleic base derivatives in water under mild conditions.
2002 May 21
Synthesis of some novel quinoline-3-carboxylic acids and pyrimidoquinoline derivatives as potential antimicrobial agents.
2002 Nov
Synthesis and characterization of new linear pi-conjugated molecules containing bis(ethynylpyridine) units with a benzothiadiazole spacer.
2002 Nov 1
Homoazanicotine: a structure-affinity study for nicotinic acetylcholine (nACh) receptor binding.
2002 Oct 10
The unusual role of CO transfer in molybdenum-catalyzed asymmetric alkylations.
2002 Oct 30
X-ray diffraction and (1)H NMR in solution: structural determination of lanthanide complexes of a Py(2)N(6)Ac(4) ligand.
2002 Oct 7
Enzymatic synthesis and characterization of oligosaccharides structurally related to the repeating unit of Pullulan.
2002 Sep 20
Potent and selective inhibitors of PDGF receptor phosphorylation. 2. Synthesis, structure activity relationship, improvement of aqueous solubility, and biological effects of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.
2002 Sep 26
Site of protonation of nicotine and nornicotine in the gas phase: pyridine or pyrrolidine nitrogen?
2002 Sep 4
Regioselective substitution of 6,7-dichloroquinoline-5,8-dione: synthesis and X-ray crystal structure of 4a,10,11-triazabenzo[3,2-a]fluorene-5,6-diones.
2003 Apr 17
Distance dependence of electron transfer across peptides with different secondary structures: the role of Peptide energetics and electronic coupling.
2003 Apr 2
Substituted aminopyridines as potent and selective phosphodiesterase-4 inhibitors.
2003 Feb 24
NMR evaluation of the configurational stability of Cu(I) complexes.
2003 Jan 27
Localization of defined carbohydrate epitopes in bovine polysialylated NCAM.
2003 Jan-Feb
N-glycan structures of human transferrin produced by Lymantria dispar (gypsy moth) cells using the LdMNPV expression system.
2003 Jul
Speciation study of the anti-inflammatory drug tenoxicam (Htenox) with Cu(II): X-ray crystal structure of [Cu(tenox)(2)(py)(2)].EtOH.
2003 Jun 1
Investigations into the interactions between DNA and conformationally constrained pyridylamineplatinum(II) analogues of AMD473.
2003 Jun 2
Bis(2-aminopyridinium) maleate.
2003 Mar
Patents
Substance Class Chemical
Created
by admin
on Sat Jun 26 11:19:57 UTC 2021
Edited
by admin
on Sat Jun 26 11:19:57 UTC 2021
Record UNII
WSX981HEWU
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2-AMINOPYRIDINE
HSDB  
Systematic Name English
NSC-431
Code English
.ALPHA.-AMINOPYRIDINE
MI  
Common Name English
MEPYRAMINE MALEATE IMPURITY C [EP]
Common Name English
.ALPHA.-AMINOPYRIDINE [MI]
Common Name English
2-PYRIDINAMINE
Systematic Name English
TENOXICAM IMPURITY A [EP]
Common Name English
PYRIDIN-2-AMINE
Systematic Name English
PIROXICAM RELATED COMPOUND A [USP-RS]
Common Name English
2-AMINOPYRIDINE [HSDB]
Common Name English
PIROXICAM SPECIFIED IMPURITY A [EP]
Common Name English
AMINOPYRIDINE, 2-
Systematic Name English
Code System Code Type Description
HSDB
2068
Created by admin on Sat Jun 26 11:19:58 UTC 2021 , Edited by admin on Sat Jun 26 11:19:58 UTC 2021
PRIMARY
MERCK INDEX
M1739
Created by admin on Sat Jun 26 11:19:58 UTC 2021 , Edited by admin on Sat Jun 26 11:19:58 UTC 2021
PRIMARY Merck Index
EPA CompTox
504-29-0
Created by admin on Sat Jun 26 11:19:58 UTC 2021 , Edited by admin on Sat Jun 26 11:19:58 UTC 2021
PRIMARY
CAS
504-29-0
Created by admin on Sat Jun 26 11:19:58 UTC 2021 , Edited by admin on Sat Jun 26 11:19:58 UTC 2021
PRIMARY
PUBCHEM
10439
Created by admin on Sat Jun 26 11:19:58 UTC 2021 , Edited by admin on Sat Jun 26 11:19:58 UTC 2021
PRIMARY
MESH
C032439
Created by admin on Sat Jun 26 11:19:58 UTC 2021 , Edited by admin on Sat Jun 26 11:19:58 UTC 2021
PRIMARY
WIKIPEDIA
2-AMINOPYRIDINE
Created by admin on Sat Jun 26 11:19:58 UTC 2021 , Edited by admin on Sat Jun 26 11:19:58 UTC 2021
PRIMARY
ECHA (EC/EINECS)
207-988-4
Created by admin on Sat Jun 26 11:19:58 UTC 2021 , Edited by admin on Sat Jun 26 11:19:58 UTC 2021
PRIMARY
USP_CATALOG
1544519
Created by admin on Sat Jun 26 11:19:58 UTC 2021 , Edited by admin on Sat Jun 26 11:19:58 UTC 2021
PRIMARY USP-RS
FDA UNII
WSX981HEWU
Created by admin on Sat Jun 26 11:19:58 UTC 2021 , Edited by admin on Sat Jun 26 11:19:58 UTC 2021
PRIMARY
EVMPD
SUB117598
Created by admin on Sat Jun 26 11:19:58 UTC 2021 , Edited by admin on Sat Jun 26 11:19:58 UTC 2021
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
correction factors: for the calculation of content, multiply the peak areas of the following impurities by the corresponding correction factor: impurity A = 0.2
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
For the calculation of contents, multiply the peak areas by 0.6
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY